FDA Adverse Event Injury Summary report: N

ACCU-CHEK ® AVIVA

MDR report key: 2033594 · Received March 30, 2011

Report

Report Number
1823260-2011-01697
Event Type
Injury
Date Received
March 30, 2011
Date of Event
January 2, 2011
Report Date
March 30, 2011
Manufacturer
ROCHE DIAGNOSTICS
Product Code
NBW
PMA / PMN Number
K043474
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

REPORTER ALLEGED HE ATTEMPTED TO TEST ON THE AVIVA SYSTEM WHEN WAS HURTING ALL OVER AND FELT SICK TO HIS STOMACH BUT COULDN'T GET A RESULT DUE TO AN ERROR MESSAGE. REPORTER STATED THAT HE WAS DRIVEN TO THE HOSPITAL AND A RESULT AROUND 500-800 MG/DL WAS OBTAINED ON THEIR SYSTEM BEFORE HE WAS ADMITTED AND TREATED INTRAVENOUSLY. REPORTER STATED THAT HE WAS PUT IN A STEP DOWN UNIT OF THE HOSPITAL AND KEPT FOR 6 DAYS. NO OTHER ACTIONS WERE REPORTED TAKEN OR TREATMENT RECEIVED. A REQUEST WAS MADE FOR THE RETURN OF THE SUSPECT DEVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCU-CHEK ® AVIVA BLOOD GLUCOSE MONITORING DEVICE NBW ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 051 YR Hospitalization| R POTASSIUM CHLORIDE (TWICE DAILY)| OXYCODONE| MAGNESIUM OXIDE (DAILY)| ALBUTEROL INHALER| ASPIRIN (DAILY)| NITROGLYCERIN| "LETROPROLOL" (TWICE DAILY)| CANE| WHEELCHAIR| WALKER| BLOOD PRESSURE CUFF (LIFE SOURCE)| VALSARTAN (TWICE DAILY)| SIMVASTATIN (DAILY)| OMEPRAZOLE (DAILY)| LEVOTHYROXINE (DAILY)| GLARGINE| ASPART| GABAPENTIN (DAILY)| CLONIDINE PATCH (WEEKLY)